REQUEST A DEMO
Total
USD $0.00
Search more companies

CLC Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: CLC Pharma Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

CLC Pharma Kft. is based in Hungary. The head office is in Herceghalom. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was first established on July 28, 1994. CLC Pharma Kft. currently employs 2 (2020) people. The company’s latest financial report indicates a net sales revenue increase of 60.14% in 2024. A growth of 78.02% was recorded in its total assets. In 2024, CLC Pharma Kft.’s net profit margin increased by 1.8%.

Headquarters
Zsambeki ut 220/1.
Herceghalom; Pest; Postal Code: 2053

Contact Details: Purchase the CLC Pharma Kft. report to view the information.

Website: http://www.cafeland.hu

Basic Information
Total Employees:
Purchase the CLC Pharma Kft. report to view the information.
Registered Capital:
Purchase the CLC Pharma Kft. report to view the information.
Financial Auditors:
Purchase the CLC Pharma Kft. report to view the information.
Incorporation Date:
July 28, 1994
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after CLC Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
60.14%
Total operating revenue
60.45%
Operating profit (EBIT)
72.12%
EBITDA
71.88%
Net Profit (Loss) for the Period
97.42%
Total Assets
78.02%
Total Equity
43.54%
Operating Profit Margin (ROS)
0.69%
Net Profit Margin
1.8%
Return on Equity (ROE)
10.18%
Debt/Equity
86.27%
Quick Ratio
-0.06%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?